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Visual Impairment Intracranial Pressure  
Syndrome Signs 
MRI Orbital 
Image 
showing 
globe 
flattening  
Normal Globe Flatten Globe 
•Choroidal Folds 
- parallel grooves in 
the posterior pole 
•Globe Flattening  
•Optic Disc Edema (swelling)  
•Altered Blood flow 
•“cotton wool” spots  
•Hyperopic Shifts 
-Up to +1.75 diopters  
•Increased Optic Nerve 
Sheath Diameter 
2 
ICP 
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VIIP Clinical Findings 
• To date 15 U.S. ISS long-duration spaceflight astronauts 
have developed some or all of the following findings:  
 
• Hyperopic shift  
• Choroidal folds  
• Cotton wool spots  
• Optic Nerve Sheath Distention 
• Globe flattening  
• Edema of the Optic disc (papilledema)  
 
 
•  High postflight intracranial pressure in four crew members: 
• 15.4-21.3mmHg (Normal: 7-15mmHg) or, 
• 21-29 cmH2O, Normal: 9.5-20.4cmH2O 
 
 
 
 
Signs of elevated 
intracranial pressure 
Eye  
Findings 
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Initial Identification of the VIIP: 
Subjective Changes in Vision 
• 50% of long- duration (ISS) mission 
astronauts report a subjective degradation in 
vision, primarily increasing farsightedness 
• Hyperopic shift 
 
Decreased near visual acuity, distant vision intact 
Hyperopic Eye 
Normal Eye 
(1 mm decrease in axial length is equivalent to a 3 diaper hyperopic shift)  
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Pre to Post Flight Papilledema: A Clinical 
Sign of Raised Intracranial Pressure 
Pre Flight 
Fundoscopic images of 
the right and left optic 
disc.  
Post Flight 
Fundoscopic images of 
the right and left optic 
disc showing Grade 3 
edema right and Grade 
1 edema left .   
Pre Flight 
OD 
Post Flight 
OD 
OS 
OS 
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In Flight B-scan Ultrasound 
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Mean ONSD Measurement & ICP 
Because of a variable pressure-diameter relationship, the clinical relevance of this 
method relies on the demonstration of ongoing enlargement on serial US studies. 
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ISS Inflight Crew Ultrasound Imaging: 
Additional Signs of Raised Intracranial Pressure 
1. Increased Optic Nerve Sheath Diameter 
Terrestrial Normal<5.9mm 
2. Posterior Globe Flattening 
Flattening of Posterior Globe  
3. Raised Optic Disc 
Preflight Postflight 
Postflight 
Postflight 
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Choroidal Folds 
Postflight 
OD             OS 
 
Postflight 
OD                
 
 
Preflight                   Postflight 
Inferior            Superior      Inferior                       Superior 
  
Thickening of the 
choroid secondary 
to venous blood 
engorgement from 
uG fluid shift 
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 Class 1 ≥ .50 diopter cycloplegic refractive change and/or cotton wool spot  
  
 
10 
VIIP Clinical Practice Guideline  
Case Definition 
Class 2 ≥ .50 diopter cycloplegic refractive changes or cotton wool spot 
• Choroidal folds and/or optic nerve sheath distension and/or globe flattening 
and/or scotoma 
 
Class 3  ≥ .50 diopter cycloplegic refractive changes and/or cotton wool spot 
• Optic nerve sheath distension, and/or globe flattening and/or choroidal 
folds and/or scotoma 
• Papilledema of Grade 0-2.  
 
Class 4 ≥ .50 diopter cycloplegic refractive changes and/or cotton wool spot 
• Optic nerve sheath distension, and/or globe flattening and/or choroidal 
folds and/or scotoma 
• Papilledema Grade 2 or above. 
• Presenting symptoms of new headache, pulsatile tinnitus and/or 
transient visual obscurations 
• CSF opening pressure >25 cm H2O 
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Current U.S. ISS VIIP Incidence: 
 41 U.S. ISS astronauts flown to date as of Expedition 32: 
– Unclassified astronauts N=16 (No MRI, OCT or ocular US)  
– Non-cases N=6 
– Confirmed cases: 19 
 
– Class One N=2 
– Class Two N=11 
– Class Three N=2 
– Class Four N=4 
 
 
 
 
68.4 % Class 1&2 
31.6 % Class 3&4 
Current VIIP Incidence as a % of U.S. ISS astronauts tested= 76.0%  
Increasing 
severity 
Clinical Classification: 
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Cardiovascular CNS  Ocular 
+ + 
Primary Systems Involved 
Visual Impairment and Elevated Intracranial 
Pressure in Spaceflight 
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Cephalad Fluid Shift 
13 
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Loss of Hydrostatic Drainage & 
Cerebral Venous Congestion 
Adapted from Rowell, 1988 
X 
Loss of  
 Hydrostatic Drainage 
9.8m/s2 
1G 0G 
C
EPH
ALA
D
 FLU
ID
 SH
IFT 
1G Supine 
Adapted from Hargens & Richardson, Respiratory Physiology & Neurobiology. 2009 
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Tilt Angle vs ICP & CVP: Positional Fluid 
Shifts 
1. Chapman et al. The Relationship between Ventricular Fluid Pressure and Body Position in Normal Subjects with Shunts. Neurosurgery 1990 
ICP-2.3mmHg 
ICP 9.2mmHg 
ICP 25mmHg 
CVP=0mmHg 
CVP=5mmHg 
CVP=9mmHg 
2. Hemodynamic changes due to Trendelenburg positioning and pneumoperitoneum during laproscopic hysterectomy, Acta  Anaesthesiologica 
Scandiavica. 1995 
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-2 
7-9 
X 
0G 
Redistribution of Venous Pressures  
From 1G to 0G 
 Cranium is rigid 
 Venous congestion 
 Obligate arterial flow 
 Transcapillary leak 
 ++ICP~30-40 
9.8m/s2 
15-20  
3. Chapman et al. The Relationship between Ventricular Fluid Pressure and Body Position in Normal Subjects with Shunts. Neurosurgery 1990 
1. Hirvonen et al.  Hemodynamic changes due to Trendelenburg positioning and pneumoperitoneum during laproscopic hysterectomy, Acta  Anaesthesiologica Scandiavica. 1995 
4. Gisolf  et al. Human cerebral outflow pathway depends on posture and central venous pressure. Journal of Physiology, 2004. 
2. Hinghofer-Szalkay  Gravity, the hydrorostatic indifference concept and  the cardiovascular system. European Journal of Applied Physiology, 2010 
ICP = CSFout resistance  x CSFformation + SSSpressure 
Standing 1G 
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Jugular Vein Pressure & ICP Increases in 
Simulated Microgravity 
 Jugular bulb pressure approximates dural sinus pressure 
 Jugular vein pressure measured in 7 animals during 4.5s free drop 
 Loss of hydrostatic pressure gradient increased JVP 1.3mmHg 
• i.e. loss of hydrostatic assisted venous drainage 
 Similar study, ICP increased in 5 rats from 4.8 to 7.3 mmHg =52% increase in ICP 
 Factors that may further raise ICP: 
• Complete cephalad fluid shift, Increased CO2  
 
 
0 3 4 1 -4 2 -1 -2 -3 
4.8mmHg 
7.3mmHg 
2. GOTOH et al. Cerebral Circulation during Acute Microgravity Induced by Free Drop in Anesthetized Rats Japanese Journal of Physiology, 53, 223–228, 2003 
0.4 mmHg 
1.7 mmHg 
1. Gotoh et al. Acute hemodynamic responses in the head during microgravity induced by free drop in anesthetized rats. Am J Physiology-Regulatory Integrative & Comparative Physiology. 2004 
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VIIP Ocular Findings in ISS Astronauts 
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MRI in Idiopathic Intracranial Hypertension  
& VIIP: The Case for Elevated ICP 
Maralani et al. Accuracy of brain imaging in the diagnosis of idiopathic intracranial 
hypertension. Clinical Radiology. Dec. 2011. 
Kramer et al. Orbital and Intracranial Effects of Microgravity: Findings at 3-T MR Imaging. Radiology: 
Volume 263: Number 3—June 2012  
 
IIH MRI Signs vs VIIP 
 
Imaging Assessment Present in IIH (Specificity) Seen in VIIP 
Venous Stenosis Score 100% ? 
Flattening of Posterior 
Globes 100% Yes 
Optic Nerve Protrusion 100% Yes 
Partially Empty Sella 95.3% Yes 
Optic Nerve Sheath 
Distension 88.4% Yes 
Optic Nerve Tortuosity 86% Yes 
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Vascular Capacitance: 
Venous & Arterial 
20%=1L 
70-80%=4L 
Page No. 21 
Venous Compliance 
Vein 
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Factors Increasing Venous Tone will Increase 
Cerebral Venous Outflow Resistance 
 Resting Tone of Venous Vessels 
Influenced by: 
• SNS tone↑ 
Resting Blood Pressure 
• Endothelin↑ 
• Nitric oxide↓ 
• Inflammatory cytokines ↑ 
 
(CVP) 
Although effects 
of tone less on 
venous side vs 
arterial, volume 
is much greater 
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Metabolic Syndrome 
Hypertension Hyperglycemia Hypertri- glyceridemia 
Elevated LDL 
Decreased HDL 
Impaired 
Fibrinolysis 
Hyper- 
coaguability 
Oxidative Stress 
ROS 02- 
Endothelial 
Dysfunction ↓NO2 
Inflammation 
Proliferation ↑CRP 
Vascular Dysfunction 
Metabolic Syndrome-Vascular 
Relationship 
Page No. 24 
KRRD EE NNOO W JODDB IJJ F Y S KKPP X MM SS II
R
AA
T
E
TT
GG U P
FF
M
N
Z
CC
0
1
2
3
4
Es
tim
at
ed
 &
 O
bs
er
ve
d 
C
PG
 S
co
re
s
10 15 20 25 30 35
Pre-Flight % Body Fat
Estimation for Cases with 95% CI Non-Cases Cases
Best Fit (curvilinear) for Cases; R2=.38, p<.01
       
Occupational Surveillance Data Mining: 
Percentage Body Fat 
VIIP Classification vs %Fat 
(Annual Preflight Exam) 
Athletes Obese Acceptable Fitness 
Classification 
(Men) 
%Fat 
Athletes 6-13 
Fitness 14-17 
Acceptable 18-25 
Obese 25+ 
N=35, 13 Cases, total observations=35 
Confirmed non-cases (Green) & unclassified (Blue) 
Not included in model, for reference only 
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* * * *
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Pre-flight SBP
cases non-cases
Non-Linear Estimation of CPG for Cases
Sig. association of SBP with CPG score 
p=.0002 R2= 31% 
* Antihypertensive Medication 
Preflight Systolic Blood Pressure Non-Cases 
vs Cases per CPG 
N=35, Cases=13 
Confirmed non-cases (Green) & unclassified (Blue) 
Not included in model, for reference only 
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Pre-Flight Pulse Pressure
Estimation for cases with 95% CI Non-Cases Cases
Best Fit (curvilinear) for Cases; R2=.45 (including BP meds predictor), p<.01
       
(   g )
Occupational Surveillance Data Mining: 
Resting Pulse Pressure (Sitting) 
Cases per CPG vs Pulse Pressure 
(Annual Preflight Exam 4-Year Mean) 
Confirmed non-cases (Green) & unclassified (Blue) 
Not included in model, for reference only 
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Self Reported ISS Inflight Daily Sodium 
Intake 
 Current 
recommended daily 
sodium limit = 
2300mg/day 
 If 51y or high BP, 
recommended 
limit=1500mg/day 
 Applies to majority 
of U.S. adults 
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Confirmed non-case CPG-1 CPG-2 CPG-3 CPG-4
5281 
3661  
4843  
3506  3512  
------------------------------------------------------------------------------ 
             |              Jackknife 
 Sodiummgday |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
 cpg_revised |   .2186174   .1105193     1.98   0.048     .0020036    .4352312…yes … positive, but weak 
 
 Total |         5          2          9          1          4 |        21  
 Number of Astronauts per category in this Sodium analysis.  
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Occupational Data Mining in ISS Astronauts:  
Cardiovascular Variables Correlating with CPG 
 
Cardiovascular Variable 
Significant Correlation 
Across CPG 
Classification 
R2 P value 
Biochemistry: 
LDL √ 0.43 P<0.02 
HDL - 0.22 P<0.09 
Triglycerides - - 
Hemoglobin A1c √ - P<0.01 
Fasting serum glucose √ 0.125 P<0.008 
Homocysteine √ - P<0.01 
Oral sodium intake √ 0.22 P<0.05 
Body Composition: 
Body Mass Index √ 0.41 P<0.01 
Percentage Body Fat √ 0.38 P<0.01 
Cardiac: 
Resting systolic blood pressure (pre-in-post flight) √ 0.31 P<0.0002 
Pulse Pressure (pre-in-post flight) √ 0.45 P<0.01 
CT Coronary Calcium Score - - - 
Aerobic Capacity: 
Decreased Maximal Oxygen Uptake √ - P<0.04 
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Key Brain Areas Affected by Fluid Shift 
CSF Production 
CSF Resorbtion 
(AG-Venous/Lymphatic) 
Venous 
Congestion 
Interstitial fluid 
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Pressure and Compliance Changes in the 
Craniospinal Axis 
Resistance to cerebral 
venous drainage 
R
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to
 c
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F 
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t 
CVR=CPP/CBF     CPP=MAP-ICP 
ICP = CSFout resistance  x CSFformation + SSSpressure 
Venous CSF Craniospinal 
Axis 
CSF & Venous 
P1 
P2 
(↑ P2) (↑ P1) 
↑ICP 
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Venous Congestion May Cause Increased 
Transcapillary Pressure & Decreased Absorbtion 
↑Venous 
Pressure 
X 
Interstitial edema 
+10mmHg -7mmHg 
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Venous Congestion & Interstitial Edema Inhibit 
Lymphatic CSF Drainage-Impacts on Optic Nerve 
X X 
X 
X 
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The Translaminar Pressure  
Gradient: A Mechanism for Papilledema 
1G 0G 
CSFp 
IOP 
Area of Interest: 
Area of Magnification 
Translaminar Pressure Gradients: 
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RNFL Pre RNFL Post
RNFL Pre & Post ISS by CPG Classification
OCT: Average RNFL Change in VIIP 
Cases Pre to Postflight 
Sig difference in RNFL 
Pre to Postflight for CPG 
3&4. p<0.01 
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IOP for Six Shuttle Missions (12 Subjects) 
Pre-flight, In-flight-Post-flight 
IOP mmHg 
Glaucoma Medically 
Controlled Ocular Hypotension 
Ocular Hypertension 
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Mean IOP Pre & Postflight in ISS Crew per VIIP CPG: 
Does Low IOP Predispose to Papilledema Formation? 
Sig difference between CPG 3-4 vs CPG 0 
Postflight p<0.04 (All 5 CPG 3-4 cases represented Pre/Post) 
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Translaminar Pressure Difference &  
Visual Field Defect 
ICP IOP TLP Delta 
10 15 -5 5 
25 17 +8 13 
35 17 +18 23 
Examples: 
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CO2 Levels on ISS 
 CO2 is an extremely potent vasodilator  
• Every 1mmHg increase PaCO2=4% 
increase in dilation 
 
 CO2 mission average=3.56mmHg (0.33%) 
• 10x normal sea level atmospheric: 0.0314% 
• Average Peak CO2=8.32mmHg (0.7%) (20x) 
 
 CO2 may cause increased CSF production due to increased 
flux of HCO3 -  across choroid plexus & accompanying  H2O 
 
Cephalad Fluid Shift 
CO2 
X 
X 
Adapted from Alperin et al. Radiology, 2000 
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Increased BP with Elevated CO2 
Causing Decreased Compliance 
CPP=MAP-ICP 
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Cerebral Blood Volume Change with 
Changing PaCO2 
@ 37, CBV = 0.041 Paco,+ 2 
=3.52 
@45mmHg CBV = 0.041 Paco,+ 2 
3.85 
Diff=.33ml/100 
.33x12 
4ml 
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Cerebral Blood Flow Velocity During 
Hypercapnia &10o HDT + Hypercapnia 
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Data mining – Contributions of CO2 to 
the VIIP syndrome 
 
 PI:  TBD 
 Aims: This retrospective data mining effort will evaluate the in-flight 
CO2 levels during flight with the time course of identified visual 
changes experienced by crew members to determine if increase CO2 
levels could be a contributing factor to the VIIP syndrome.    
 
 Zwart et al. 2012 found a difference in CO2 concentrations between 
cases and non-cases: 
• In-flight cabin CO2 concentrations were higher (P <0.05) for OC+ 
(N=5) than OC- astronauts (N=15). 
 
 
* P < 0.05 Zwart et al. Journal of Nutrition. Feb 2012. 
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Limit Resistive Training: 
Resistive Exercise 
Does in-flight resistance 
training cause additional 
transient elevations in 
ICP? 
60 
Resistive Exercise Repetitions causing 
spikes in ICP 
(1 hour x 5 sessions per week) 
Max 2-Leg Press with Valsalva  CVP↑ 56mmHg 
Max 2-Leg Press no Valsalva  CVP↑ 9mmHg 
Pott et al. J Applied Physiol. 2003 
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 Microgravity Dose Response for the VIIP? 
 Kramer et. al. Orbital and Intracranial Effects of Microgravity: Findings at 3-T 
MR Imaging. Radiology: Vol 263:3 2012  
 N=27 Astronauts, mean time to MR imaging was 606 days +/- 822  
 18 group 1 astronauts underwent imaging more than 100 days after flight   
 Consistently higher percentage of findings for group with greater microgravity 
exposure, and increased severity of findings. 
Cumulative Lifetime Exposure to Microgravity Relative to Imaging Findings 
Time in UG  No. 
Subjects 
Globe 
Flattening 
Optic Nerve 
Sheath 
Kinking 
ONSD>5.9
mm 
Optic Disc 
Protrusion 
Moderate 
or Greater 
Pituitary 
Concavity 
<30d 
(Short) 
12 1 1 5 0 0 
>30d 
(Long) 
15 6 3 9 4 3 
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A Working Model: Potential Interaction of the 
CNS, Vascular, & Ocular System in the VIIP 
+VP 
+CSFP 
+OVP 
+OCSFP 
9.8m/s2 X 
Hydrostatic Drainage 
Loss of  
 
Cerebral 
Venous Blood 
Adapted from Rekate 
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Supplemental O2 as a Treatment Option 
 As the arterial tension of CO2 rises, CBF increases, when it is reduced 
vasoconstriction is induced. 
 Hyperventilation can lead to a mean reduction in intracranial pressure of 
about 50% within 2-30 minutes.  
 
Ruben B H. "Intracranial hypertension" in Advances in Anaesthesia. Edit. Gallagher T J. p.1, London Year Book Medical Publishers Inc. 1984.  
22.5 45 67.5 90 
40 mmHg=normal 
0 
PaCO2 mmHg 
Supplemental O2 to drive down 
PaCO2 & venous congestion/ICP 
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Correlation of ONSD & Visual Field Deficit 
 T. Salgarello et al. Optic nerve diameters and perimetric thresholds in idiopathic 
intracranial hypertension. British Journal of Ophthalmology 1996;80:509-514 
 20 patients with IIH (mean age=47) papilledema grade 1.1(range 0-4), 20 controls 
 CSF pressure=260-320mmH2O, Mean duration disease=7.65 years 
 Perimetric defects in 70% of eyes (28/40) 
 Deficit associated with papilledema grade 
MD: Average deviation from age matched 
controls 
PSD: Measure of visual field irregularities 
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Blind Spot Enlargement Following Papilledema 
Regained normal 
disc appearance 
Chronic Disc Changes 
Papilledema grade Δ 2.25 to 0.9 
Papilledema grade Δ 
1.9 to 0 
Normal Blind Spot Area 
 Sorenson et al. Clinical course and prognosis of 
pseudotumor cerebri. A prospective study of 24 
patients. Acto Neurol Scand., 1988:77:164-172 
 24 IIH patients, symptoms present 1-30 
months 
 Median CSFp=25mm Hg (range 8-45), all had 
papiledema initially 
 Followed for 49 months, treated with Diamox 
and diuretics 6-18 months 
 Patients who regained normal disc (50%) had 
shorter duration of disease (median=4 months) 
vs those who developed chronic changes 
(median=12months) 
 Visual field testing not conducted 
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Visual Loss Associated with Papilledema Grade 
 M.Wall. Asymmetric Papilledema in Idiopathic Intracranial Hypertension: Prospective 
Interocular Comparison of Sensory Visual Function. IOVS, Jan.1998, Vol. 39, No. 1 
 9 IIH patients (mean age=31.8) with asymmetric papilledema 2+ grade diff.  
• High grade=3 (2-5) vs Low grade=1 (0-2) 
 Mean CSFp=347.2 mm H2O 
 Visual loss most prominent in eye with higher grade papilledema 
 High grade papilledema should be regarded as a risk factor for visual loss 
Depression of the visual island with 
increasing papilledema grade 
The Visual Island 
Normal 
Low Grade Papill. 
High Grade Papill. 
Profile Perimetry 
Page No. 55 
Mild Papilledema and Visual Field Loss 
 G. Rebolleda et al. Follow-up of Mild Papilledema in 
Idiopathic Intracranial  Hypertension with Optical 
Coherence Tomography. IOVS. 2009 Vol 50, No 11 
 N=22, mean age=40, recent diagnosis of IIH 
 Mild papilledema, mean= Frisen 2 (range 1-3) 
 Mean CSFp=35cmH2O (range 25.5-45) 
 1 Year follow-up: 
• Perimetry: 66% normal VF, 18% enlargement blind 
spot, 16% irreversible field loss 
• OCT: 10 RNFL thinner than normal (3 visual field 
constriction, 3 inferonasal defects, 1 had a scotoma) 
 RNFL swelling and attrition may occur simultaneously 
 Perimetry needed with OCT, since OCT cannot 
distinguish between decreased swelling vs axonal loss 
 Both OCT and perimetry required for F/U 
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Visual Field Damage Following Regression of 
Papilledema 
 R. Laemmer. Detection of nerve fiber atrophy in apparently 
effectively treated papilledema in idiopathic intracranial 
hypertension. Graefes Arch Clin Exp Ophthalmol (2010) 
248:1787–1793 
 23 IIH patients, mean age 33.8, 23 controls 
 Mean follow-up in patients with regression of 
papilledema=27 months 
 8/13 (63%) regressive papilledema group had 
mild-moderate concentric visual field damage-
superior and inferior regions 
 Patients with papilledema, only 1/10 
detectable visual field loss 
 Data show significant reduction RNFL as a 
sign of axon loss in patients with apparently 
treated papilledema 
 Minor loss of axons will be masked by 
structure of retina, with overlapping receptive 
fields. Thus, 40% of RNFL may be lost before 
occurrence of visual field damage 
Mild Severe Normal 
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 Microgravity Dose Response for the VIIP? 
 Kramer et. al. Orbital and Intracranial Effects of Microgravity: Findings at 3-T 
MR Imaging. Radiology: Vol 263:3 2012  
 N=27 Astronauts, mean time to MR imaging was 606 days +/- 822  
 18 group 1 astronauts underwent imaging more than 100 days after flight   
 Consistently higher percentage of findings for group with greater microgravity 
exposure, and increased severity of findings. 
Cumulative Lifetime Exposure to Microgravity Relative to Imaging Findings 
Time in UG  No. 
Subjects 
Globe 
Flattening 
Optic Nerve 
Sheath 
Kinking 
ONSD>5.9
mm 
Optic Disc 
Protrusion 
Moderate 
or Greater 
Pituitary 
Concavity 
<30d 
(Short) 
12 1 1 5 0 0 
>30d 
(Long) 
15 6 3 9 4 3 
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Monroe Kelly Principle & ICP 
Accommodation of up to 
120ml volume change while 
maintaining normal ICP 
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Fluid Shift & Inadequate Cerebral Venous & CSF 
Accommodation May Increase ICP in 0G 
0G Cephalad fluid shift causes venous blood & CSF outflow resistance 
Venous congestion 
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Increased CSF Vol., Venous Congestion, & 
Increased interstitial Vol. 
 Alperin et. al. MRI Evidence of Impaired CSF Homeostasis in Obesity-Associated 
Idiopathic Intracranial Hypertension. AJNR. July, 2012  
• 3D volumetric MR imaging 
• N=11 IIH newly diagnosed non-treated women vs N=11 overweight healthy women 
Cranial Volumetric Measurements 
ICCSF:Intracranial CSF, EVCSF: Extraventricular CSF, GM: Grey Matter, ICV: Intracranial Vol, 
Nor VCSF: Normalized Ventricular CSF,  Nor EVCSF: Normalized Extraventricular CSF 
Arterial & Venous Volumetric Flow Rate Measurements 
C
ontrol 
IIH
 
•   Less venous volume draining via the IJV 
•   Likely increased drainage via secondary vessels 
•   Implying an increased resistance to venous outflow 
Grey Matter=Blue 
White matter=Yellow 
CSF=Red 
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Prolonged Elevations in ICP and 
Impaired Cognition 
 Sorenson et al. Persistent disturbances of cognitive 
functions in patients with pseudotumor cerebri. Acta 
Neurol Scand. 1986 
• Prospective  
• N=5, mean papilledema 2, mean ICP 25.6 mmHg.  
• Difficulties in learning and memory for 6-30 months.  
• Testing showed a slight impairment in verbal tests.  
• At 12 month follow-up, after intensive medical or surgical 
treatment in 4/5 subjects the intellectual impairment 
reversed, and papilledema had resolved in 4 patients 
 
 Walton, D. Language deficits in patients with IIH. Thesis.1999 
• Prospective  
• N=9, All subjects experienced mild deficits in short term memory and 
auditory processing of linguistic information.  
• Particular difficulty in following complex directions containing prepositional 
information and in immediate recall of words or numbers. 
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• Kharkar et al. Cognitive impairment in patients 
with pseudotumor cerebri syndrome. 
Behavioural Neurology, 2011.  
 Retrospective N=10. Cognitively tested at presentation 
 80% had an impairment in memory and learning: 
 
 
 
 
 
 
 
 
 
 
 
• Concept of cognitive reserve in mild Cognitive 
Impairment 
 L l f d i  d   i h d i  l d   hi h  
          
      
 
Prolonged Elevations in ICP and Impaired 
Cognition- Cont’d 
2 SD 1SD 
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